Your browser doesn't support javascript.
loading
Proficiency tests to evaluate the impact on assay outcomes of harmonized influenza-specific Intracellular Cytokine Staining (ICS) and IFN-É£ Enzyme-Linked ImmunoSpot (ELISpot) protocols.
Waerlop, Gwenn; Leroux-Roels, Geert; Pagnon, Anke; Begue, Sarah; Salaun, Bruno; Janssens, Michel; Medaglini, Donata; Pettini, Elena; Montomoli, Emanuele; Gianchecchi, Elena; Lambe, Teresa; Godfrey, Leila; Bull, Maireid; Bellamy, Duncan; Amdam, Håkon; Bredholt, Geir; Cox, Rebecca Jane; Clement, Frédéric.
Afiliação
  • Waerlop G; Center for Vaccinology (CEVAC), Ghent University and University Hospital, Ghent, Belgium. Electronic address: Gwenn.Waerlop@UGent.be.
  • Leroux-Roels G; Center for Vaccinology (CEVAC), Ghent University and University Hospital, Ghent, Belgium.
  • Pagnon A; Sanofi, Research Global Immunology, Marcy l'Etoile, France.
  • Begue S; Sanofi, Research Global Immunology, Marcy l'Etoile, France.
  • Salaun B; GSK, Rixensart, Belgium.
  • Janssens M; GSK, Rixensart, Belgium.
  • Medaglini D; Laboratory of Molecular Microbiology and Biotechnology, Department of Medical Biotechnologies, University of Siena, Siena, Italy.
  • Pettini E; Laboratory of Molecular Microbiology and Biotechnology, Department of Medical Biotechnologies, University of Siena, Siena, Italy.
  • Montomoli E; Department of Molecular and Developmental Medicine, University of Siena, Siena, Italy; VisMederi srl, 53100 Siena, Italy.
  • Gianchecchi E; VisMederi srl, 53100 Siena, Italy.
  • Lambe T; Oxford Vaccine Group, Department of Paediatrics, Medical Sciences Division, University of Oxford, UK; Chinese Academy of Medical Science (CAMS) Oxford Institute (COI), University of Oxford, United Kingdom.
  • Godfrey L; Oxford Vaccine Group, Department of Paediatrics, Medical Sciences Division, University of Oxford, UK.
  • Bull M; Oxford Vaccine Group, Department of Paediatrics, Medical Sciences Division, University of Oxford, UK; Chinese Academy of Medical Science (CAMS) Oxford Institute (COI), University of Oxford, United Kingdom.
  • Bellamy D; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
  • Amdam H; Influenza Centre, Department of Clinical Science, University of Bergen, N5021 Bergen, Norway.
  • Bredholt G; Influenza Centre, Department of Clinical Science, University of Bergen, N5021 Bergen, Norway.
  • Cox RJ; Influenza Centre, Department of Clinical Science, University of Bergen, N5021 Bergen, Norway.
  • Clement F; Center for Vaccinology (CEVAC), Ghent University and University Hospital, Ghent, Belgium.
J Immunol Methods ; 523: 113584, 2023 12.
Article em En | MEDLINE | ID: mdl-37918618

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra Influenza / Influenza Humana Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra Influenza / Influenza Humana Idioma: En Ano de publicação: 2023 Tipo de documento: Article